Telomere damage induces internal loops that generate telomeric circles.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 10 2020
Historique:
received: 14 02 2020
accepted: 28 09 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 25 11 2020
Statut: epublish

Résumé

Extrachromosomal telomeric circles are commonly invoked as important players in telomere maintenance, but their origin has remained elusive. Using electron microscopy analysis on purified telomeres we show that, apart from known structures, telomeric repeats accumulate internal loops (i-loops) that occur in the proximity of nicks and single-stranded DNA gaps. I-loops are induced by single-stranded damage at normal telomeres and represent the majority of telomeric structures detected in ALT (Alternative Lengthening of Telomeres) tumor cells. Our data indicate that i-loops form as a consequence of the exposure of single-stranded DNA at telomeric repeats. Finally, we show that these damage-induced i-loops can be excised to generate extrachromosomal telomeric circles resulting in loss of telomeric repeats. Our results identify damage-induced i-loops as a new intermediate in telomere metabolism and reveal a simple mechanism that links telomere damage to the accumulation of extrachromosomal telomeric circles and to telomere erosion.

Identifiants

pubmed: 33082350
doi: 10.1038/s41467-020-19139-4
pii: 10.1038/s41467-020-19139-4
pmc: PMC7576219
doi:

Substances chimiques

DNA, Single-Stranded 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5297

Références

EMBO J. 2012 May 16;31(10):2309-21
pubmed: 22531781
Biochemistry. 1980 Jun 24;19(13):2977-92
pubmed: 6249343
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12430-5
pubmed: 19581589
Nucleic Acids Res. 1983 Aug 11;11(15):5073-91
pubmed: 6308571
Mol Cell Biol. 1990 Feb;10(2):518-27
pubmed: 2300052
Proc Natl Acad Sci U S A. 1975 Jan;72(1):83-7
pubmed: 164030
Mutat Res. 1990 Jan;237(1):29-36
pubmed: 2320037
Mol Cell Biol. 1996 May;16(5):2002-14
pubmed: 8628266
Genes (Basel). 2019 Apr 24;10(4):
pubmed: 31022960
Mol Cell Biol. 2004 Nov;24(22):9948-57
pubmed: 15509797
J Cell Biol. 2012 Dec 10;199(6):893-906
pubmed: 23229897
Curr Biol. 2007 Nov 20;17(22):1989-95
pubmed: 18006317
Mol Cell. 2007 Jul 6;27(1):163-9
pubmed: 17612498
EMBO J. 2009 Apr 8;28(7):799-809
pubmed: 19214183
Nat Struct Mol Biol. 2014 Feb;21(2):167-74
pubmed: 24413054
Nat Struct Mol Biol. 2017 Jan;24(1):30-39
pubmed: 27918544
Cell. 1997 Dec 26;91(7):1033-42
pubmed: 9428525
DNA Repair (Amst). 2020 Oct;94:102901
pubmed: 32620538
Science. 2004 Dec 10;306(5703):1951-3
pubmed: 15591207
Science. 2017 Feb 10;355(6325):638-641
pubmed: 28082411
Cell. 2009 Jul 10;138(1):90-103
pubmed: 19596237
J Cell Biol. 2004 Jul 19;166(2):161-5
pubmed: 15249582
Cell. 2004 Oct 29;119(3):355-68
pubmed: 15507207
Nat Struct Mol Biol. 2017 Sep;24(9):734-742
pubmed: 28805810
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
PLoS Genet. 2019 Feb 4;15(2):e1007925
pubmed: 30716077
Mol Cell Biol. 2009 Feb;29(3):703-13
pubmed: 19015236
Nat Struct Mol Biol. 2009 Oct;16(10):1010-5
pubmed: 19809492
Science. 1976 Jul 2;193(4247):62-4
pubmed: 935855
EMBO J. 1992 Feb;11(2):717-24
pubmed: 1537344
Cell. 2012 May 11;149(4):795-806
pubmed: 22579284
Methods Mol Biol. 2009;521:605-31
pubmed: 19563131
Methods Mol Biol. 2011;731:93-103
pubmed: 21516400
Mol Cell Biol. 2004 Oct;24(19):8437-46
pubmed: 15367665
Nucleic Acids Res. 2006 Mar 01;34(4):e34
pubmed: 16510851
Nucleic Acids Res. 2006;34(20):6044-50
pubmed: 17071963
Front Genet. 2019 Aug 14;10:792
pubmed: 31475042
Cell. 1999 May 14;97(4):503-14
pubmed: 10338214
Nat Rev Mol Cell Biol. 2017 Mar;18(3):175-186
pubmed: 28096526

Auteurs

Giulia Mazzucco (G)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Armela Huda (A)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Martina Galli (M)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Daniele Piccini (D)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Michele Giannattasio (M)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.
Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Via Festa del Perdono 7, Milan, 20122, Italy.

Fabio Pessina (F)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Ylli Doksani (Y)

IFOM, the FIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy. ylli.doksani@ifom.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH